Encompass Wealth Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,276
Closed -$389K 110
2025
Q3
$389K Buy
15,276
+423
+3% +$10.4K 0.13% 78
2025
Q2
$360K Buy
14,853
+1,094
+8% +$25.5K 0.13% 79
2025
Q1
$349K Buy
13,759
+73
+0.5% +$1.91K 0.14% 74
2024
Q4
$363K Buy
13,686
+1,560
+13% +$42.3K 0.15% 75
2024
Q3
$351K Buy
12,126
+16
+0.1% +$467 0.09% 179
2024
Q2
$339K Buy
12,110
+506
+4% +$13.9K 0.09% 174
2024
Q1
$322K Buy
11,604
+346
+3% +$9.6K 0.09% 188
2023
Q4
$324K Sell
11,258
-190
-2% -$5.74K 0.1% 162
2023
Q3
$380K Sell
11,448
-488
-4% -$17.3K 0.13% 140
2023
Q2
$438K Buy
11,936
+328
+3% +$12.8K 0.14% 129
2023
Q1
$474K Buy
11,608
+35
+0.3% +$1.51K 0.16% 115
2022
Q4
$593K Buy
11,573
+22
+0.2% +$1.05K 0.22% 88
2022
Q3
$505K Buy
11,551
+509
+5% +$24.7K 0.19% 98
2022
Q2
$579K Sell
11,042
-543
-5% -$27.7K 0.2% 92
2022
Q1
$600K Sell
11,585
-10
-0.1% -$519 0.15% 113
2021
Q4
$685K Sell
11,595
-19
-0.2% -$941 0.17% 102
2021
Q3
$499K Sell
11,614
-1,634
-12% -$72.4K 0.13% 124
2021
Q2
$518K Sell
13,248
-2,010
-13% -$78.2K 0.13% 131
2021
Q1
$609K Buy
15,258
+2,136
+16% +$75.8K 0.16% 117
2020
Q4
$483K Buy
+13,122
New +$481K 0.28% 65

Other funds holding PFE

Encompass Wealth Advisors's PFE Position: Q4 2025 in Review

Encompass Wealth Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 15,276 shares — an estimated $389K sold.

Encompass Wealth Advisors first reported a position in PFE in Q4 2020 and held it in 20 quarters. The position peaked at $685K in Q4 2021. 2,915 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Encompass Wealth Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Encompass Wealth Advisors sold 15,276 Pfizer shares in Q4 2025, an estimated $389K.
  • Encompass Wealth Advisors first reported a position in Pfizer in Q4 2020 and held it in 20 quarters.
  • Encompass Wealth Advisors's Pfizer position peaked at $685K in Q4 2021.
  • 2,915 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Encompass Wealth Advisors's 13F filing for Q4 2025, filed 22 Jan 2026.